IGC Pharma (IGC) Institutional Ownership → I’m afraid WWIII is a very real possibility (From Porter & Company) (Ad) Free IGC Stock Alerts $0.56 -0.04 (-6.67%) (As of 05/17/2024 ET) Add Compare Share Share OwnershipStock AnalysisChartEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesOwnershipSEC FilingsShort Interest Institutional Ownership Changes (13F Filings) for IGC Pharma (NYSEAMERICAN:IGC)CurrentInstitutional OwnershipPercentage3.87%Number ofInstitutional Buyers(last 12 months)1Number ofInstitutional Sellers(last 12 months)0 Get IGC Insider Trade Alerts Want to know when executives and insiders are buying or selling IGC Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data IGC Institutional Buying and Selling by Quarter Ad Porter & CompanyI’m afraid WWIII is a very real possibility As one top U.S. cyber official claims: This [tech] is “the most powerful weapon of our time.” That's also why I've produced this new film.Take a look. IGC Pharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails10/23/2023Commonwealth Equity Services LLC165,490$59K0.0%+211.3%0.308% 7/20/2022 Dearborn Partners LLC125,026$66K0.0%+29.0%0.242% 7/19/2022Commonwealth Equity Services LLC50,250$26K0.0%N/A0.097% 6/2/2022 Mirae Asset Global Investments Co. Ltd.1,377,257$1.31M0.0%-17.1%2.698% 5/10/2022 Mirae Asset Global Investments Co. Ltd.1,377,257$1.31M0.0%-17.1%2.698% 4/28/2022 Davy Global Fund Management Ltd97,235$92K0.0%-93.8%0.190% Get the Latest News and Ratings for IGC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for IGC Pharma and its competitors with MarketBeat's FREE daily newsletter. 2/8/2022 Mirae Asset Global Investments Co. Ltd.1,661,393$1.62M0.0%+310.7%3.254% 2/2/2022 Davy Global Fund Management Ltd1,579,278$1.54M0.2%+11.7%3.094% 11/16/2021 Two Sigma Securities LLC19,866$29K0.0%-38.4%0.039% 11/15/2021 Marshall Wace LLP20,750$31K0.0%N/A0.041% 11/12/2021 Renaissance Technologies LLC436,800$646K0.0%+46.5%0.856% 11/12/2021Vident Investment Advisory LLC56,330$83K0.0%N/A0.110% 10/27/2021 Davy Global Fund Management Ltd1,413,876$2.09M0.3%+26.9%2.770% 9/17/2021Virtu Financial LLC190,293$312K0.0%N/A0.382% 8/17/2021 Bridgeway Capital Management LLC209,000$343K0.0%-16.0%0.432% 8/16/2021 State Street Corp216,878$356K0.0%N/A0.449% 8/13/2021 Renaissance Technologies LLC298,115$489K0.0%N/A0.617% 8/13/2021 Geode Capital Management LLC272,005$446K0.0%+3.9%0.563% 8/13/2021 Vanguard Group Inc.654,272$1.07M0.0%-8.4%1.354% 8/12/2021 Penserra Capital Management LLC56,068$98K0.0%N/A0.116% 7/31/2021 Davy Global Fund Management Ltd1,114,415$1.83M0.3%+33.4%2.306% 5/17/2021 Price T Rowe Associates Inc. MD43,000$77K0.0%N/A0.095% 5/11/2021 Davy Global Fund Management Ltd835,363$1.50M0.3%N/A1.841% 5/11/2021 Vontobel Holding Ltd.120,000$212K0.0%N/A0.265% 4/6/2021Carroll Financial Associates Inc.320,000$572K0.0%-28.1%0.705% 2/24/2021Virtu Financial LLC21,135$33K0.0%N/A0.047% 2/5/2021 BlackRock Inc.909,222$1.42M0.0%+3,167.5%2.125% 1/8/2021Carroll Financial Associates Inc.445,000$694K0.0%-13.6%1.040% 10/7/2020 Powell Investment Advisors LLC25,000$26K0.0%N/A0.061% 8/31/2020 Bridgeway Capital Management Inc.127,200$76K0.0%N/A0.309% 8/7/2020Virtu Financial LLC109,493$66K0.0%N/A0.266% 7/9/2020Carroll Financial Associates Inc.515,000$308K0.0%+139.5%1.310% 5/1/2020 BlackRock Inc.94,544$47K0.0%+176.0%0.240% (Data available from 1/1/2016 forward) IGC Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of IGC shares? During the previous two years, the following institutional investors and hedge funds held shares of IGC Pharma shares: Mirae Asset Global Investments Co. Ltd. ($1.31M), and Dearborn Partners LLC ($66K), Commonwealth Equity Services LLC ($59K).Learn more on IGC's institutional investors. What percentage of IGC Pharma stock is owned by institutional investors? 3.87% of IGC Pharma stock is owned by institutional investors. Learn more on IGC's institutional investor holdings. Which institutional investors have been buying IGC Pharma stock? The following institutional investors have purchased IGC Pharma stock in the last 24 months: Commonwealth Equity Services LLC ($162.58K), and Dearborn Partners LLC ($28.13K). How much institutional buying is happening at IGC Pharma? Institutional investors have bought a total of 190,709 shares in the last 24 months. This purchase volume represents approximately $41.54K in transactions. Which IGC Pharma major shareholders have been selling company stock? The following institutional investors have sold IGC Pharma stock in the last 24 months: Mirae Asset Global Investments Co. Ltd. ($284.14K). How much institutional selling is happening at IGC Pharma? Institutional investors have sold a total of 284,136 shares in the last 24 months. This volume of shares sold represents approximately $269.62K in transactions. Related Companies: PMN Institutional Ownership MRKR Institutional Ownership SNSE Institutional Ownership PTN Institutional Ownership CARA Institutional Ownership LEXX Institutional Ownership SPRB Institutional Ownership FBIO Institutional Ownership XLO Institutional Ownership BCTX Institutional Ownership This page (NYSEAMERICAN:IGC) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaMost important medical advance in 100 yearsThe Oxford ClubThe Presidential candidate you should REALLY be worried aboutStansberry ResearchMake this ONE trade on Tuesday at 2 p.m. EST!Monument Traders AllianceBiden Nomination CANCELED?The Freeport SocietyUrgent Nvidia WarningAltimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IGC Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
